This Article Full Text (PDF) All Versions of this Article: 41/2/199    most recent 01.HYP.0000049761.98155.7Bv1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lip, G. Y.H. Search for Related Content PubMed PubMed Citation Articles by Lip, G. Y.H. Pubmed/NCBI databases Medline Plus Health Information High Blood Pressure Related Collections Transplantation Thrombosis risk factors Clinical Studies Platelets Endothelium/vascular type/nitric oxide

Hypertension, Platelets, and the Endothelium. The "Thrombotic Paradox" of Hypertension (or "Birmingham Paradox") Revisited

From the Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, England.

^* To whom correspondence should be addressed. E-mail: G.Y.H.LIP{at}bham.ac.uk.

This article has been cited by other articles:

				G. I Varughese, J. V Patel, J. Tomson, and G. Y H Lip Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillation Heart, April 1, 2007; 93(4): 495 - 499. [Abstract] [Full Text] [PDF]

				A. W.J.H. Dielis, M. Smid, H. M.H. Spronk, K. Hamulyak, A. A. Kroon, H. ten Cate, and P. W. de Leeuw The Prothrombotic Paradox of Hypertension: Role of the Renin-Angiotensin and Kallikrein-Kinin Systems Hypertension, December 1, 2005; 46(6): 1236 - 1242. [Abstract] [Full Text] [PDF]

				E. Arikan and S. Sen Endothelial Damage and Hemostatic Markers in Patients with Uncomplicated Mild-to-Moderate Hypertension and Relationship with Risk Factors Clinical and Applied Thrombosis/Hemostasis, April 1, 2005; 11(2): 147 - 159. [Abstract] [PDF]

				S. K. Nadar, A. D. Blann, S. Kamath, D. G. Beevers, and G. Y. H. Lip Platelet indexes in relation to target organ damage in high-risk hypertensive patients: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) J. Am. Coll. Cardiol., July 21, 2004; 44(2): 415 - 422. [Abstract] [Full Text] [PDF]

				H. S. Lim and G. Y. H. Lip Is Angiotensin Receptor Blockade Antithrombotic? Arch Intern Med, December 8, 2003; 163(22): 2790 - 2791. [Full Text] [PDF]